The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells

HDAC6 Modulates Cell Motility by Altering the Acetylation Level of Cortactin

Xiaohong Zhang, Zhigang Yuan, Yingtao Zhang et al. · Molecular Cell · 2007 · 714 citations · Full text

Signal Transduction, Molecular Regulation, Physiology +8

Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally

Yu Zhang, So-Hee Kwon, Teppei Yamaguchi et al. · Molecular and Cellular Biology · 2008 · 548 citations · Full text

Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder Mann, John R. Johnson, Kun He et al. · Clinical Cancer Research · 2007 · 260 citations · Full text

Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer

Shigehira Saji, Masayo Kawakami, Shin‐ichi Hayashi et al. · Oncogene · 2005 · 258 citations

Tumor Biology, Breast Oncology, Medicine +11

Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6

Yuliya Zilberman, Christoph Ballestrem, Letizia Carramusa et al. · Journal of Cell Science · 2009 · 227 citations